The declaration of the Mpox outbreak in Africa as a public health emergency is a critical post-COVID test for the international community, writes @DrEmeruemJnr. https://t.co/1PdXJoyyGC
Securing donor financing for #globalhealth requires engaging in the political game -meeting the needs of politicians and relevant civil servants. #CHIntHealthFinancing panel discussion on motivations/rationales for public international financing of GH priorities. #Chathamhouse
👁🗨With access to health care high on people`s priorities and electorates judging their political leaders on their COVID-19 responses, now could be the best time to campaign for bold health reforms to reach universal health coverage, writes @yates_rob.
🔗https://t.co/ZOlb6ScyRg
💬 "Britain’s policy is indicative of the lack of solidarity that has been shown by governments & politicians″ - @yates_rob comments on Britain's poor performance in the COVAX programme & countries' tit for tat reactions over vaccine programmes and travel
https://t.co/sbC0NGCs34
#COVID19 forcing the facing of so many long-running tensions. What does “global public good” badge really mean 4 access 2 medicine and #innovation/pharma engagement? Very tough issue, with a lot at stake on both sides. #intellectualproperty@CHGlobalHealth https://t.co/5MyErRwfHQ
The terrible damage that polio inflicted decades ago has been overcome through collaboration - 'wealthy countries making sure that people in poorer countries are vaccinated.’
The way to beat coronavirus is through equitable vaccine distribution, says @yates_rob
Vaccine nationalism is resulting in rich countries procuring quantities multiple times the size of their population.
This failure to collectively combat the pandemic poses a threat to global health security, writes @yates_rob
https://t.co/7D7CRP0n3A
#epidemiology veteran David Heymann on returning int travel 2 its #BC19 level. Long rd ahead. https://t.co/JFoRgqj2hh. Join us next Fri @ChathamHouse as we talk border cntrls and returning 2 int travel w Kelley Lee @profplum8 & @IATA DG de Juniac https://t.co/xCZzp97oPG
#COVID19 variants and vaccines - more insight on where we are, where we're heading, the challenges we're facing and likely scenario, with @ChathamHouse#pandemic experts David Heymann and David Salisbury. join us Wednesday 1600 GMT. https://t.co/0RTZW0Hktc
As @alanbeattie warned in @FT on 18 Jan, "childish point-scoring" is not helpful to UK's international relations, especially with EU.
EU won't be doing the UK any favours as it now considers whether to restrict exports of the Pfizer vaccine from EU-based production facilities
The vaccine wars are here and they're ugly.
How the AstraZeneca debacle is pitting EU vs UK, marking a nasty turn in the rich world while poorer countries' hopes of mass immunization soon are diminishing.
@benjmueller & I report
https://t.co/DhSRwvyy08